Physiopathology of Spine Metastasis
暂无分享,去创建一个
Giulio Maccauro | G. Maccauro | M. A. Rosa | C. Graci | M. Spinelli | C. Perisano | Maria Silvia Spinelli | Sigismondo Mauro | Carlo Perisano | Calogero Graci | Michele Attilio Rosa | S. Mauro | M. Rosa
[1] S. Rabbani,et al. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. , 1994, Cancer research.
[2] T. Rosol. Pathogenesis of Bone Metastases: Role of Tumor‐Related Proteins , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] L. Hofbauer,et al. The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[4] H. V. Crock,et al. Observations on the venous drainage of the human vertebral body. , 1973, Journal of Bone and Joint Surgery-british Volume.
[5] W. Stetler-Stevenson,et al. Matrix metalloproteinases and metastasis , 1999, Cancer Chemotherapy and Pharmacology.
[6] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[7] V. Kähäri,et al. Matrix metalloproteinases in tumor invasion , 2000, Cellular and Molecular Life Sciences CMLS.
[8] D. Togawa,et al. The Pathophysiology of Spinal Metastases , 2006 .
[9] J. Greenberger. The pathophysiology and management of spine metastasis from lung cancer , 2005, Journal of Neuro-Oncology.
[10] J. Izbicki,et al. Early metastasis of human solid tumours: expression of cell adhesion molecules. , 1995, Ciba Foundation symposium.
[11] D. Connolly,et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.
[12] E. Bauer,et al. Role of the extracellular matrix in the degradation of connective tissue , 2004, Archives of Dermatological Research.
[13] Jing Wu,et al. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. , 2002, Cancer research.
[14] D. R. Coman,et al. The role of the vertebral venous system in the metastasis of cancer to the spinal column. Experiments with tumor‐cell suspensions in rats and rabbits , 1951, Cancer.
[15] E. Bonucci. Physiopathology of cancer metastases in bone and of the changes they induce in bone remodeling , 2002 .
[16] K. Yonenobu,et al. Orthopaedic management of spinal metastases. , 1995, Clinical orthopaedics and related research.
[17] V. Kähäri,et al. Matrix metalloproteinases in squamous cell carcinoma. , 2000, Histology and histopathology.
[18] G. T. Krishnamurthy,et al. Distribution pattern of metastatic bone disease. A need for total body skeletal image. , 1977, JAMA.
[19] B F Boyce,et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.
[20] J. Hayman,et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. , 1991, Cancer research.
[21] E. Keller,et al. The role of Wnts in bone metastases , 2007, Cancer and Metastasis Reviews.
[22] Y. DeClerck. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. , 2000, European journal of cancer.
[23] G. David Roodman. Role of stromal‐derived cytokines and growth factors in bone metastasis , 2003, Cancer.
[24] Judith P. Johnson. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease , 1991, Cancer and Metastasis Reviews.
[25] G. Powell,et al. Localization of parathyroid hormone‐related protein mrna expression in breast cancer and metastatic lesions by in situ hybridization , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] N. Clarke,et al. Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases , 2002, British Journal of Cancer.
[27] G. Tuszynski,et al. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis , 2009, Pathology Oncology Research.
[28] J. Heimans,et al. Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. , 1992, AJR. American journal of roentgenology.
[29] R Wieser,et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.
[30] James H. Doroshow,et al. Abeloff's Clinical Oncology , 2013 .
[31] R. Coleman. Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.
[32] K. Honn,et al. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix , 1992, Cancer and Metastasis Reviews.
[33] R. Sanderson,et al. Matrix Metalloproteinases in Multiple Myeloma , 2000, Leukemia & lymphoma.
[34] F. Orr,et al. Pathophysiologic interactions in skeletal metastasis , 2000, Cancer.
[35] J. Chirgwin,et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Chirgwin,et al. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases , 2007, Cancer and Metastasis Reviews.
[37] J. Posner,et al. Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment , 1978, Annals of neurology.
[38] T. Guise,et al. Cancer and bone. , 1998, Endocrine reviews.
[39] O. Batson. The function of the vertebral veins and their role in the spread of metastases. 1940. , 1995, Clinical orthopaedics and related research.
[40] Z. Werb,et al. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. , 2001, Trends in cell biology.
[41] R. Fechner. Bone tumors: Clinical, radiologic and pathologic correlations: Joseph M. Mirra, Philadelphia, PA, Lea & Febiger, 1989, 1,833 pages (volumes 1 & 2 combined), $250 , 1990 .
[42] A. Angelucci,et al. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines , 2004, Clinical & Experimental Metastasis.
[43] Jonathan B. Cohen. Tumors and Tumorous Conditions of the Bones and Joints. Henry L. Jaffe, M.D. Philadelphia, Lea and Febiger, 1958. $18.50 , 1958 .
[44] W. Stetler-Stevenson,et al. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. , 1994, The European respiratory journal.
[45] Y. M. Yang,et al. Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption , 2000, British Journal of Cancer.
[46] K. Harrington. Orthopedic surgical management of skeletal complications of malignancy , 1997, Cancer.
[47] S. Rabbani,et al. Molecular basis of the spectrum of skeletal complications of neoplasia , 2000, Cancer.
[48] B. Gainor,et al. A Profile of Metastatic Carcinoma of the Spine , 1985, Spine.
[49] A. Lipton. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention. , 2004, The journal of supportive oncology.
[50] P. Siegel,et al. Breast cancer-derived factors facilitate osteolytic bone metastasis. , 2006, Bulletin du cancer.
[51] O. V. Batson. THE RÔLE OF THE VERTEBRAL VEINS IN METASTATIC PROCESSES , 1942 .
[52] S. Ménard,et al. Expression of Bone Sialoprotein in Human Lung Cancer , 1997, Calcified Tissue International.
[53] K. Honn,et al. Adhesion molecules and tumor metastasis: an update. , 1994, Invasion & metastasis.
[54] F. Mansfield,et al. One-stage posterolateral decompression and stabilization for primary and metastatic vertebral tumors in the thoracic and lumbar spine. , 1989, Journal of neurosurgery.
[55] Zuxiong Chen,et al. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. , 1996, The Journal of urology.
[56] K P Dingemans,et al. Mechanisms of metastasis. , 1979, Biochimica et biophysica acta.
[57] E. Ogata,et al. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. , 2000, Biochemical and biophysical research communications.
[58] O. V. Batson. THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES , 1940, Annals of surgery.
[59] I. Stamenkovic. Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.
[60] P. Black. Spinal metastasis: current status and recommended guidelines for management. , 1979, Neurosurgery.
[61] G. Roodman,et al. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. , 1995, The Journal of clinical investigation.
[62] C. Galasko. Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.
[63] N. Clarke,et al. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies , 2002, British Journal of Cancer.
[64] E. Baldi,et al. Endothelin‐1 production by prostate cancer cell lines is up‐regulated by factors involved in cancer progression and down‐regulated by androgens , 2001, The Prostate.
[65] J. Nelson,et al. Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.
[66] L. Liotta,et al. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] V. Castronovo,et al. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. , 2000, Circulation research.
[68] L. Weiss,et al. Organ vascularity and metastatic frequency. , 1980, The American journal of pathology.
[69] N. Clarke,et al. Morphometric evidence for bone resorption and replacement in prostate cancer. , 1991, British journal of urology.
[70] Yi Zhang,et al. Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] R. Hutter,et al. Neoplasms of the spine in the aged. , 1963, Clinical orthopaedics and related research.
[72] G. Roodman. Mechanisms of bone metastasis. , 2004, Discovery medicine.
[73] L. Liaw,et al. Functions of the extracellular matrix and matrix degrading proteases during tumor progression. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[74] R. Baggs,et al. Pathogenesis of vertebral metastasis and epidural spinal cord compression , 1990, Cancer.
[75] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.
[76] G. Mundy. Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.
[77] K. Kelly,et al. Mechanisms of cancer metastasis to the bone , 2005, Cell Research.
[78] J. Glowacki,et al. Stromal Cell-Mediated Stimulation of Osteoclastogenesis , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[79] B. Fingleton,et al. Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] S. Zucker,et al. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. , 2001, Drug discovery today.
[81] J. Starkey. Cell-matrix interactions during tumor invasion , 1990, Cancer and Metastasis Reviews.
[82] M. Stack,et al. Membrane associated matrix metalloproteinases in metastasis. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[83] J. Posner,et al. Management of spinal epidural metastases. , 1983, Clinical neurosurgery.
[84] N Sundaresan,et al. Treatment of neoplastic spinal cord compression: results of a prospective study. , 1991, Neurosurgery.
[85] Jonathan N Grauer,et al. Metastatic Disease of the Spine , 2006, The Journal of the American Academy of Orthopaedic Surgeons.
[86] M. Duffy. The role of proteolytic enzymes in cancer invasion and metastasis , 1992, Clinical & Experimental Metastasis.
[87] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.